Trial
NCT01426074
DCE-MRI PET Bevacizumab Study in Rectal Cancer
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
—
Condition
Rectal Cancer Patients
Intervention
Bevacizumab 5 mg/kg
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-21